CS MEDICA Stock Now Also Traded on XETRA
Enhanced Liquidity and Trading Opportunities for Shareholders
CS MEDICA (“CS MEDICA” or “The Company”), a MedTech pioneer specializing in pain management and autoimmune diseases with innovative substance-based medical devices containing bioactive CBD, has been trading on the Frankfurt Stock Exchange since March 2, 2023. The company is now pleased to announce that its shares are also available on Deutsche Börse AG's XETRA trading platform, facilitated by the private bank Hauck Aufhäuser Lampe.
Deutsche Börse AG imposes stringent criteria on Designated Sponsors for liquidity provision. Hauck Aufhäuser Lampe has consistently achieved the highest rating ('AA') from Deutsche Börse for its excellence in this area.
"By including our shares on the XETRA trading platform, we offer both existing and future shareholders an additional trading opportunity," says Lone Henriksen, CEO of CS MEDICA A/S.
By committing to a Designated Sponsor, CS MEDICA aims to increase the liquidity of its stock and improve the free float.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/
CS MEDICA A/S, a Danish MedTech pioneer, specializes in developing evidence-based, CBD-integrated treatments for pain management, autoimmune and stress-related disorders. With a focus on patient-centric care, our products range from innovative R&D to registered over-the-counter substance-based medical devices and dermaceuticals. Our flagship CANNASEN® brand, alongside our own-label solutions, exemplifies our dedication to safe, high-quality treatments for both human and veterinary health globally.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information, visit cs-medica.com and LinkedIn.
CANNORDIC A/S, a subsidiary of CS MEDICA Group, is a pioneering MedTech company specializing in innovative substance-based medical devices containing bioactive CBD. Our dedication to enhancing lives by integrating innovation, science, technology, and natural cannabis compounds positions it as a pioneer in the medical technology industry. The company ensures robust research, development, manufacturing, compliance, data insights, and commercialization processes.
Tags: